Arca
Skip to content
Tools
Tools

PAGA: Protective antigen

Protein in Bacillus anthracis that 5 drugs act on.

  • Drugs that act on it: 5
  • Approved: 3
  • In phases 1 to 3: 2
  • Sponsors: 4

Who is on it, and how far along

Every drug ChEMBL records acting on PAGA, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Antibody 2
  • Other 3

Approved3

Phase 30

    Phase 20

      Phase 12

      • AVP-21D9
      • MDX-1303

      Sponsors

      Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
      RaxibacumabBoxed warningApprovedGSKAntibodyBinding agentProtective antigen binding agent2
      Bacillus anthracis protective antigen, adsorbedApproved—OtherVaccine antigenProtective antigen vaccine antigen0
      ObiltoxaximabBoxed warningApprovedElusys TherapeuticsAntibodyBinding agentProtective antigen binding agent0
      AVP-21D9Phase 1Emergent BioSolutionsOtherInhibitorProtective antigen inhibitor0
      MDX-1303Phase 1PharmAthene, Inc.OtherInhibitorProtective antigen inhibitor0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 2 in all, from ClinicalTrials.gov.
      Observational Study of Raxibacumab in Sporadic Cases of Systemic AnthraxRaxibacumab—Not yet recruitingEmergent BioSolutionsMar 17, 2026
      Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure ScenarioRaxibacumabPhase 4Not yet recruitingEmergent BioSolutionsJun 30, 2014

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL5352, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.